AccessHope
Overview
AccessHope, LLC is a healthcare company that delivers cutting-edge cancer care expertise across the United States. Founded in 2019, its primary mission is to democratize access to leading cancer treatment knowledge by leveraging collaborations with National Cancer Institute (NCI)-designated Comprehensive Cancer Centers. AccessHope is headquartered in Duarte, California, and was founded through a partnership with City of Hope, a prominent cancer research and treatment institution. The company has raised $33 million in a Series B funding round, with City of Hope as a key investor, and recently expanded its executive leadership with the appointment of Brad Kreick as CEO.
Recent Developments
- June 2024: AccessHope announced a strategic collaboration with UT Southwestern Harold C. Simmons Comprehensive Cancer Center, marking the addition of the seventh NCI-designated center to its network. This partnership aims to enhance cancer treatment access in the southern United States, particularly in Texas, Arkansas, Louisiana, and Oklahoma. Oncologists from Simmons Cancer Center will review cases for AccessHope’s employer plan members, facilitating optimized cancer treatment plans (source: PR Newswire).
- April 2024: AccessHope secured $33 million in Series B funding to drive product development, expand its oncology network, and enter new markets like health plans and Medicare. City of Hope provided this strategic funding, which aids AccessHope’s transformation into a more autonomous and commercially focused entity (source: MyAccessHope).
- March 2024: AccessHope was recognized by BenefitsPRO in the Luminaries Class of 2024, under the Rising Star category, highlighting its innovative approach to expanding cancer care benefits and improving access to specialist knowledge for employees in the U.S. (source: Finance Yahoo).
- 2023: Johns Hopkins Medicine joined AccessHope’s network, increasing the availability of expert cancer case reviews. This expansion supports AccessHope's mission to deliver leading cancer expertise to members across the U.S. by collaborating with NCI-Designated Comprehensive Cancer Centers (source: MyAccessHope).
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2019 |
| Headquarters | Duarte, California |
| Founders | City of Hope |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | City of Hope |
| Industry | Healthcare, Cancer Care |
| Number of Employees | Approximately 400 |
Early History
AccessHope was established in 2019 as an initiative by City of Hope, one of the nation's leading cancer research and treatment institutions, to extend expert cancer care beyond geographical barriers. Originally conceived to bridge gaps in cancer treatment accessibility, the company formed collaborations with NCI-designated Comprehensive Cancer Centers. These collaborations aim to provide tailored cancer treatment knowledge to patients' local oncologists, ensuring high-quality care without the need to travel to specialized centers. In its early years, AccessHope focused on building a robust network of expert partners and establishing itself as a unique player in the healthcare sector.
Company Profile and Achievements
AccessHope operates by integrating cancer expertise from prominent NCI-designated centers into the local care frameworks across the U.S. This is achieved without requiring patients to leave their current healthcare providers. The business model revolves around providing expert reviews of cancer cases, aiding local doctors in formulating precise treatment plans. Some of the significant milestones include:
- Forming partnerships with leading cancer centers such as City of Hope, Dana-Farber Cancer Institute, and Emory Healthcare, among others.
- Raising $33 million in Series B funding to further its mission and expand operations internationally and across various healthcare markets.
- Recognition as an innovator in the healthcare benefits space by BenefitsPRO for its contributions to improving cancer care accessibility.
- Serving nearly seven million members through collaborations with over 400 employers, including numerous Fortune 500 companies. AccessHope’s strategies focus on expanding its service offerings through technological advancements and strategic partnerships, ensuring it remains at the forefront of cancer care innovation.
Current Operations and Market Position
Currently, AccessHope is recognized for its unique positioning in the healthcare market, focusing on cancer treatment accessibility. It connects with leading cancer institutions to provide members with the latest insights and personalized treatment strategies. By 2024, AccessHope had expanded its network, bringing more expertise to underserved regions across the United States. The company’s collaboration with NCI-designated Comprehensive Cancer Centers ensures that patients across different localities have access to world-class cancer care while remaining in their communities.
Conclusion
AccessHope, LLC plays a pivotal role in transforming the landscape of cancer treatment by decentralizing access to specialized expertise. Its model not only broadens access to leading-edge cancer care but also optimizes treatment strategies for millions of patients. By continuously expanding its network and innovating within its service model, AccessHope aims to reduce cancer health disparities and provide equitable care nationwide. As it continues on its trajectory of growth, AccessHope is poised to become a cornerstone in the realm of personalized cancer treatment, bridging gaps in care availability and advancing health equity.